BIOLOGICAL · Unmapped registry intervention
Allogeneic Human E-islet (E-islet 01)
Find medicine records ·
Find other trials using this name
Clinical trial
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
NCT07126873
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetes Mellitus, Type 1unresolved
Impaired Hypoglycemic Awarenessunresolved
Severe Hypoglycemiaunresolved
Interventions
Allogeneic Human E-islet (E-islet 01)BIOLOGICAL
Sponsors & collaborators
EndoCell Therapeutics, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07126873 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.